|
HTC
|
|
|
Headquartered in the Cleveland Health-Tech Corridor, CardioInsight Technologies Inc. is commercializing a breakthrough patented electrocardiographic imaging technology that will significantly improve the diagnosis and treatment of a number of critical heart conditions. The company’s Electrocardiographic Mapping (ECM) technology non-invasively images electrical activity on the surface of the heart, combining body surface electrical data and chest CT scans to generate maps of the electrical activity of the heart during each heart beat.
ECM provides more information than electrocardiograms a by reconstructing and displaying 3D images and other useful measures of cardiac electrical activity as if the measurements were taken directly from the surface of the heart. The technology has wide application in the diagnosis of electrical abnormalities during various cardiac diseases and guiding appropriate therapy.
The technology’s strengths in guiding the treatment of arrhythmias and heart failure have been demonstrated in more than 260 patient studies at clinical centers, including University Hospitals of Cleveland, the Cleveland Clinic Foundation, Loyola University Medical Center, the University of Pennsylvania Medical Center, and Hôpital Cardiologique du Haut–Lévèque in Bordeaux, France.
CardioInsight was founded in 2006 by researchers at Case Western University, and has raised over $12 million in funding from Jumpstart Inc., Draper Triangle Ventures, the Case Office of Technology Transfer, company management, Haissaguerre Ventures, and the Ohio Third Frontier Program - through the Global Cardiovascular Innovation Center, and Ohio Capital Fund.
CardioInsight is completing clinical trials and developing its current prototype into a salable product. It recently entered into an investment and distribution agreement with Tokyo’s DVx, a leading Asian distributor of cardiovascular devices. DVx will lead regulatory and marketing activities to commercialize the EC Mapping System in Japan, the world’s third largest cardiovascular market.
CardioInsight is planning to launch its EC Mapping System in Europe in June 2011 and in the U.S. later in the year.
|
|
|
|
|
|